Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 1

Recruiting

Conditions: Pancreatic Cancer

Interventions: Drug: Chemotherapy
Device: Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA)

First Posted Date: 2023-02-10

Last Posted Date: 2025-01-22

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT05723107

Locations: 🇺🇸
Tisch Hospital, New York, New York, United States

E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

Phase 2

Recruiting

Conditions: Cigarette Smoking
Opioid Use Disorder

Interventions: Behavioral: Telehealth Motivational Counseling
Drug: Nicotine Replacement Product
Device: National Institute on Drug Abuse (NIDA) Standardized Research Electronic Cigarette (SREC).

First Posted Date: 2023-02-10

Last Posted Date: 2025-03-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 302

Registration Number: NCT05722561

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States

Virtual Reality Treadmill Training in Individuals with Traumatic Brain Injury

Not Applicable

Recruiting

Conditions: Traumatic Brain Injury

Interventions: Device: C-Mill with AR/VR Guidance
Device: C-Mill without AR/VR Guidance
Device: Zeno 3-Layer Walkway
Device: Hunova

First Posted Date: 2023-02-09

Last Posted Date: 2025-02-26

Lead Sponsor: NYU Langone Health

Target Recruit Count: 20

Registration Number: NCT05721209

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders

Not Applicable

Recruiting

Conditions: Rheumatoid Arthritis

Interventions: Dietary Supplement: Butyrate

First Posted Date: 2023-02-08

Last Posted Date: 2024-12-19

Lead Sponsor: NYU Langone Health

Target Recruit Count: 35

Registration Number: NCT05718583

Locations: 🇺🇸
NYU Langone Health Orthopedic Center, New York, New York, United States

CMV Immunity Monitoring in Lung Transplant Recipients

Phase 2

Not yet recruiting

Conditions: Lung Transplant; Complications

Interventions: Device: Cytomegalovirus T Cell Immunity Panel (CMV-TCIP)
Diagnostic Test: Donor-Derived Cell-Free DNA (dd-cfDNA) Assay
Drug: Valganciclovir

First Posted Date: 2023-02-01

Last Posted Date: 2023-11-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 50

Registration Number: NCT05708755

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC

Phase 2

Terminated

Conditions: NSCLC Stage IV

Interventions: Drug: Pembrolizumab
Radiation: Radiation
Drug: Chemotherapy

First Posted Date: 2023-01-20

Last Posted Date: 2025-05-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 19

Registration Number: NCT05691829

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations

Not Applicable

Terminated

Conditions: Age-Related Macular Degeneration
Glaucoma
Diabetic Retinopathy
Central Serous Chorioretinopathy
Eye Diseases
Glaucoma, Suspect

Interventions: Device: OCT Imaging Using Device N
Device: OCT Imaging Using Device C

First Posted Date: 2023-01-17

Last Posted Date: 2024-11-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 42

Registration Number: NCT05686421

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

Phase 3

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: 18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent
Device: PET MRI Imaging

First Posted Date: 2023-01-10

Last Posted Date: 2025-04-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 26

Registration Number: NCT05678322

Locations: 🇺🇸
Smilow Comprehensive Prostate Cancer Center, New York, New York, United States

Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder

Not Applicable

Recruiting

Conditions: Problems Related to Social Environment

Interventions: Behavioral: Clinic-Level Multidimensional Intervention

First Posted Date: 2023-01-09

Last Posted Date: 2025-03-04

Lead Sponsor: NYU Langone Health

Target Recruit Count: 318

Registration Number: NCT05675735

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
University of Connecticut, Storrs, Connecticut, United States
🇺🇸
University at Buffalo, Buffalo, New York, United States

and more 1 locations

Assessment of Occult Lung Stress During Lung Protective Mechanical Ventilation

Not Applicable

Withdrawn

Conditions: Acute Respiratory Distress Syndrome

Interventions: Other: Esophageal Catheter

First Posted Date: 2023-01-09

Last Posted Date: 2025-04-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT05675696

Locations: 🇺🇸
Tisch Hospital, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy